CN Patent

CN105792851B — 修饰的治疗剂及其组合物

Assigned to Scripps Research Institute · Expires 2023-10-10 · 3y expired

What this patent protects

本发明提供了用于延长治疗剂的半衰期的方法和组合物。可将一个或多个半衰期延长部分附接至治疗剂，由此延长该治疗剂的半衰期。包含一个或多个附接至治疗剂的半衰期延长部分的修饰的治疗剂(mTA)可用于治疗有需要的受试者的疾病或状况。

USPTO Abstract

本发明提供了用于延长治疗剂的半衰期的方法和组合物。可将一个或多个半衰期延长部分附接至治疗剂，由此延长该治疗剂的半衰期。包含一个或多个附接至治疗剂的半衰期延长部分的修饰的治疗剂(mTA)可用于治疗有需要的受试者的疾病或状况。

Drugs covered by this patent

Patent Metadata

Patent number
CN105792851B
Jurisdiction
CN
Classification
—
Expires
2023-10-10
Drug substance claim
No
Drug product claim
No
Assignee
Scripps Research Institute
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.